Related Experiment Videos
Genetic versus histological grading in stereotactic biopsies
S Leenstra1, D Troost, T J Hulsebos
1Department of Neurosurgery, Academic Medical Centre, University of Amsterdam, The Netherlands.
Stereotactic and Functional Neurosurgery
|January 1, 1994
Summary
Stereotactic biopsies for astrocytoma can lead to undergrading due to tumor heterogeneity. Genetic analysis, particularly chromosome 10 and EGFR status, aids in accurate malignancy grading.
Area of Science:
- Neuro-oncology
- Cancer diagnostics
- Molecular pathology
Background:
- Diagnostic stereotactic biopsies in astrocytoma can yield false results, including undergrading.
- Tumor heterogeneity in astrocytomas can lead to sampling errors, where low-grade areas possess high-grade genetic features.
Purpose of the Study:
- To highlight the importance of accurate astrocytoma grading, especially in stereotactic biopsies.
- To emphasize the significance of genetic characterization in overcoming limitations of histological grading.
Main Methods:
- Review of existing literature on astrocytoma biopsy accuracy and heterogeneity.
- Discussion of genetic markers, including loss of heterozygosity on chromosome 10 and EGFR amplification, for malignancy grading.
Main Results:
- Undergrading of malignant astrocytomas is a significant concern due to regional heterogeneity.
- Low-grade areas within high-grade astrocytomas exhibit genetic markers of high malignancy.
- Genetic analysis, specifically chromosome 10 LOH and EGFR amplification, indicates high malignancy.
Conclusions:
- Accurate astrocytoma grading is crucial to avoid undertreatment and misrepresentation of survival data.
- Biopsies should be taken from multiple tumor regions, guided by imaging characteristics.
- Genetic grading offers a more reliable assessment of astrocytoma malignancy compared to histology alone.